Description of a chronic heart failure service model and review of pharmacotherapy in a district general hospital in comparison to Scottish Intercollegiate Guideline Network (SIGN) guidelines

Scottish Medical Journal

Volumn 53, Issue 3, 2008, Pages 28-32

  Ogundipe, Ola A ^a,c   Cordina, J ^b   Norris, C A ^a  

^a BORDERS GENERAL HOSPITAL   (United Kingdom)

^b VICTORIA HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; SPIRONOLACTONE; WARFARIN; CARDIOTONIC AGENT;

AGED; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELDERLY CARE; GENERAL HOSPITAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL CARE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NURSE PRACTITIONER; PATIENT REFERRAL; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; REVIEW; SYSTOLIC DYSFUNCTION; UNITED KINGDOM; ARTICLE; DISEASE MANAGEMENT; MEDICAL AUDIT; OUTPATIENT DEPARTMENT; SYSTOLIC HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; DIGOXIN; DISEASE MANAGEMENT; DIURETICS; HEART FAILURE, SYSTOLIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEDICAL AUDIT; OUTPATIENT CLINICS, HOSPITAL; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SCOTLAND; SPIRONOLACTONE;

EID: 54049120676     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/RSMSMJ.53.3.28     Document Type: Review

References (18)

1. Scottish Intercollegiate Guidelines Network. Management of Chronic Heart Failure. Publication Number 95. Edinburgh: SIGN, 2007. Available at http://www.sign.ac.uk (Accessed 29th December 2007)
2. Stewart S, MacIntyre K, MacLeod MM, et al. Trends in hospitalisation for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J 2001; 22: 209-217.
3. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-33.
4. Mckee SP, Leslie SJ, LeMaitre JP, et al. Physician opinions on the implementation of the SIGN guideline for heart failure. Scot Med J 2004; 49: 10-13.
5. Davie AP, McMurray JJ. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad Med J 1999; 75: 219-22.
6. Edep ME, Shah NB, Tateo IM, et al. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 1997; 30: 518-26.
7. Schreiber TL, Elkhatib A, Grines CL, et al. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol 1995; 26: 577-82.
8. McKee SP, Leslie SJ, LeMaitre JP, et al. Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail. 2003; 5: 549-555.
9. Erhardt LR, Cline CMJ. Organisation of the care of patients with heart failure. The Lancet. 1998; 352 (suppl 1): 15-18.
10. Cant B, Kohli H. A national strategy for clinical audit in Scotland. NHS Quality Improvement Scotland. Paper presented to NHS QIS Board meeting on 31 March 2005. Available at http://www.nhshealthquality.org/nhsqis/ files/Strategy%20for%20Clinical%20Audit.pdf (Accessed 29th December 2007).
11. Altimer S, Lupon J, Gonzalez B, et al. Sex and age differences in fragility in a heart failure population. Eur J Heart Fail. 2005; 7: 798-802.
12. Lien CTC, Gillespie ND, Struthers AD et al. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail. 2002; 4: 91-98.
13. Lowe G, Twaddle S. The Scottish Intercollegiate Guidelines Network (SIGN): an update. Scot Med J 2005; 50: 51-52
14. Murray M, Padfield PL, Maxwell SRJ. Does a hospital formulary influence prescribing practice in an acute medical admissions unit? Scot Med J 2005; 50: 76-79
15. Langlands A. The Health Service in a devolved Scotland. SMJ 2006; 51: 13-16
16. Scottish Executive. Partnership for Care. Edinburgh: Scottish Executive, 2003.
17. Scottish Executive. Building a Health Service Fit for the Future: a National Framework for Service Change in the NHS in Scotland. Edinburgh: Scottish Executive, 2005.
18. Scottish Executive. Delivering for Health. Edinburgh: Scottish Executive, 2005.